Bumper Offer - Urjas oil Just @ Rs. 1
Rafle 400 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Hepatic Encephalopathy. Other than this, Rafle 400 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Rafle 400 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Rafle 400 Tablet include Flatulence, Bloating or fullness, Constipation. Some other side effects of Rafle 400 Tablet have been listed ahead. Normally, these side effects of Rafle 400 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rafle 400 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Rafle 400 Tablet related warnings talks about Rafle 400 Tablet's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Rafle 400 Tablet contraindications section.
Drug interactions for Rafle 400 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Rafle 400 Tablet is safe while driving, and is is addictive in nature.
Rafle 400 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rafle 400 Tablet is used -
Moderate
Mild
Common
Is the use of Rafle 400 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Rafle. If you are pregnant, do not take Rafle without a doctor's advice.
Is the use of Rafle 400 Tablet safe during breastfeeding?
Taking Rafle may lead to serious side effects if you are breastfeeding. Rafle should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rafle 400 Tablet on the Kidneys?
Rafle is completely safe for kidneys.
What is the effect of Rafle 400 Tablet on the Liver?
Side effects of Rafle rarely affect the liver.
What is the effect of Rafle 400 Tablet on the Heart?
You can take Rafle without any fear of damage to the heart.
Rafle 400 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rafle 400 Tablet unless your doctor advises you to do so -
Is this Rafle 400 Tablet habit forming or addictive?
No, there is no any evidence that Rafle 400 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Rafle 400 Tablet as it does not make you drowsy.
Is it safe?
Yes, but take Rafle 400 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, the use of Rafle 400 Tablet in mental disorders is not effective.
Interaction between Food and Rafle 400 Tablet
Taking Rafle 400 Tablet with food is safe.
Interaction between Alcohol and Rafle 400 Tablet
Due to lack of research, there is no information about the side effects of taking Rafle 400 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
